Table 3. Case control analysis of amino acid levels on initial newborn screening.
Cases (n=32) | Controls (n=64) | p value | |
---|---|---|---|
Male Gender* | 20 (62.5) | 40 (62.5) | 1.00 |
Caucasian race* | 29 (90.6) | 58 (90.6) | 0.60 |
Birth weight (g) | 3378 (586) | 3257 (546) | 0.32 |
Gestational age (weeks) | 37.9 (1.7) | 37.9 (1.7) | 1.00 |
Age at initial newborn screening (hours) | 30.9 (8.7) | 28.3 (6.1) | 0.14 |
On TPN at the time of NBS | 2 (6.25) | 2 (3.1) | 0.60 |
Ala | 216.7 (106.9) | 196.1 (74.8) | 0.33 |
Arg | 4.2 (3.3) | 4.5 (2.4) | 0.58 |
Cit | 9.2 (3.8) | 9.9 (2.6) | 0.35 |
Glu | 148.8 (50.8) | 148.1 (38.5) | 0.93 |
Leu | 108.4 (52.6) | 100.9 (31.6) | 0.46 |
Met | 23.6 (14.4) | 22.1 (7.8) | 0.56 |
Phe | 67.3 (21.1) | 57.4 (12.2) | 0.01 |
Tyr | 53.4 (34.1) | 78.7 (41.8) | 0.003 |
Val | 88.7 (39.6) | 81.3 (21.9) | 0.33 |
Data presented as N (%). Differences between groups were analyzed by chi-square test.
All other variables presented as Mean (Standard Deviation). Metabolite levels are presented in (μmol/L) units. Differences between groups were analyzed by t-test.